Market Cap 334.50M
Revenue (ttm) 32.31M
Net Income (ttm) -237.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -733.80%
Debt to Equity Ratio 0.00
Volume 1,626,500
Avg Vol 2,385,364
Day's Range N/A - N/A
Shares Out 89.92M
Stochastic %K 40%
Beta 2.18
Analysts Sell
Price Target $3.67

Company Profile

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in No...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 401 9000
Address:
11 Hurley Street, Cambridge, United States
alexx013
alexx013 Oct. 27 at 3:12 PM
$EDIT bought @ 3.2
0 · Reply
Ebrice73
Ebrice73 Oct. 27 at 2:59 PM
0 · Reply
GoBio2022
GoBio2022 Oct. 27 at 2:31 PM
$EDIT shorts getting down and dirty
0 · Reply
JSInvestments
JSInvestments Oct. 27 at 2:17 PM
$EDIT shaping up to take a bigger beating the NTLA - makes complete sense.
0 · Reply
Robert_Dempster
Robert_Dempster Oct. 27 at 2:16 PM
$EDIT buying opportunity here🐂
0 · Reply
Ducmanallja
Ducmanallja Oct. 27 at 1:52 PM
$EDIT WTF?
0 · Reply
Whoami1989
Whoami1989 Oct. 27 at 1:42 PM
$EDIT f garbage
0 · Reply
harryvanluik
harryvanluik Oct. 27 at 1:39 PM
$EDIT NTLA already recovering. One older person with high BMI showed some bilirubin increase. NTLA decide to first take a look at this...so they paused the test themselves. No problem for EDIT...time to step in is NOW!
0 · Reply
Whoami1989
Whoami1989 Oct. 27 at 1:38 PM
$EDIT where are cheerleaders? i need you now more than ever
0 · Reply
0x126
0x126 Oct. 27 at 12:52 PM
$EDIT $NTLA tanking 45% taking us down 8%? Anyone has information? No time to listen
1 · Reply
Latest News on EDIT
Editas Medicine, Inc. - Special Call

Sep 2, 2025, 11:14 AM EDT - 7 weeks ago

Editas Medicine, Inc. - Special Call


Editas Medicine to Participate in Upcoming Investor Conferences

Aug 27, 2025, 9:00 AM EDT - 2 months ago

Editas Medicine to Participate in Upcoming Investor Conferences


Editas Medicine Announces Chief Financial Officer Transition

Mar 20, 2025, 4:01 PM EDT - 7 months ago

Editas Medicine Announces Chief Financial Officer Transition


Editas Medicine, Inc. (EDIT) Strategic Update Call Transcript

Oct 22, 2024, 11:45 AM EDT - 1 year ago

Editas Medicine, Inc. (EDIT) Strategic Update Call Transcript


Editas Medicine: A Risk/Reward Worth Considering

Sep 25, 2024, 11:46 AM EDT - 1 year ago

Editas Medicine: A Risk/Reward Worth Considering


Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 12:03 PM EDT - 1 year ago

Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript


alexx013
alexx013 Oct. 27 at 3:12 PM
$EDIT bought @ 3.2
0 · Reply
Ebrice73
Ebrice73 Oct. 27 at 2:59 PM
0 · Reply
GoBio2022
GoBio2022 Oct. 27 at 2:31 PM
$EDIT shorts getting down and dirty
0 · Reply
JSInvestments
JSInvestments Oct. 27 at 2:17 PM
$EDIT shaping up to take a bigger beating the NTLA - makes complete sense.
0 · Reply
Robert_Dempster
Robert_Dempster Oct. 27 at 2:16 PM
$EDIT buying opportunity here🐂
0 · Reply
Ducmanallja
Ducmanallja Oct. 27 at 1:52 PM
$EDIT WTF?
0 · Reply
Whoami1989
Whoami1989 Oct. 27 at 1:42 PM
$EDIT f garbage
0 · Reply
harryvanluik
harryvanluik Oct. 27 at 1:39 PM
$EDIT NTLA already recovering. One older person with high BMI showed some bilirubin increase. NTLA decide to first take a look at this...so they paused the test themselves. No problem for EDIT...time to step in is NOW!
0 · Reply
Whoami1989
Whoami1989 Oct. 27 at 1:38 PM
$EDIT where are cheerleaders? i need you now more than ever
0 · Reply
0x126
0x126 Oct. 27 at 12:52 PM
$EDIT $NTLA tanking 45% taking us down 8%? Anyone has information? No time to listen
1 · Reply
trendtrader6
trendtrader6 Oct. 26 at 3:30 PM
$ARKG weekly. at the top of the volume resistance. over 34 weekly close should confirm break out. $CRSP $EDIT
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Oct. 25 at 12:06 PM
$EDIT Trading in a wide range recently, bouncing between $3.57 and $4.14. Current price at $3.72 with average volume around 2.8 million. Volume spikes seen with price movements.
1 · Reply
0x126
0x126 Oct. 24 at 4:47 PM
$EDIT Friday green is nice after this week's senseless drop. Hope it stays at 3-4% +
0 · Reply
Awiz2
Awiz2 Oct. 24 at 1:10 PM
$EDIT The run back up begins!!!!
0 · Reply
Robert_Dempster
Robert_Dempster Oct. 24 at 12:34 PM
$EDIT downside surprise we're off to the races📈🐂🐂
0 · Reply
Robert_Dempster
Robert_Dempster Oct. 24 at 11:29 AM
$EDIT inflation data cpi 8:30 eastern should fuel The rally📈🐂
0 · Reply
Ebrice73
Ebrice73 Oct. 23 at 9:26 PM
$EDIT and we go
0 · Reply
Realy
Realy Oct. 23 at 3:20 PM
$XBI wouldn’t mind it taking 3 times to break above 111…☕️ $LABU $LABD $EDIT
0 · Reply
0x126
0x126 Oct. 23 at 10:58 AM
$EDIT would be great to stop jumping 8-10% a day and interaday
0 · Reply
DoctrBenway
DoctrBenway Oct. 22 at 4:03 PM
$EDIT Added @ 3.53
1 · Reply
0x126
0x126 Oct. 22 at 3:59 PM
$EDIT if anyone is in doubt about why we are down. Some algos, fonds and bots sell off bio sector. Next will be jump by 15-20% up due to US central bank lowing interest rates. R&D always goes up with cheap money
0 · Reply
0x126
0x126 Oct. 22 at 3:57 PM
$EDIT need cash to buy more. FML
1 · Reply